Applied DNA Sciences: Fiscal 1Q Earnings Snapshot Feb 07, 2019 Applied DNA Sciences Inc - Stock Split History | APDN ... Stock split history for Applied DNA Sciences Inc since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see … APDN - Applied Dna Scns Stock Profile - Barchart.com
By Grant Zeng, CFA NASDAQ:APDN On December 6, Applied DNA Sciences (NASDAQ:APDN) announced financial results for the fiscal fourth quarter ended September 30, 2016. Total revenue for the fiscal fourth quarter of 2016 was $1.64 million, compared to $3.98 million for the same period of 2015, a decrease of 59%. But this revenue was an increase of 151% from the $0.65
APDN - Applied DNA Sciences Inc Stock quote - CNNMoney.com Find real-time APDN - Applied DNA Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. Applied DNA Sciences, Inc. Common Stock (APDN) Pre-Market ... Applied DNA Sciences, Inc. Common Stock (APDN) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. APDN:NASDAQ CM Stock Quote - Applied DNA Sciences Inc ...
NASDAQ:APDN Applied DNA Sciences Stock Price, Forecast & News $7.36-0.62 (-7.77 %) (As of 06/5/2020 04:00 PM ET) Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed.
Feb 07, 2019 Applied DNA Sciences Inc - Stock Split History | APDN ... Stock split history for Applied DNA Sciences Inc since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see … APDN - Applied Dna Scns Stock Profile - Barchart.com Company profile for Applied Dna Scns (APDN) including business summary, key statistics, ratios, sector. Press Canadian Press Releases Cboe Options Hub Comtex Dividend Channel FreightWaves NewsBTC PR Newswire Schaeffers StockNews Zacks News. Dashboard. A stock's Profile page contains general information about the stock, such as Ticker
Applied DNA Sciences (APDN) has 1 split in our APDN split history database. The split for APDN took place on November 01, 2019. This was a 1 for 40 reverse split, meaning for each 40 shares of APDN owned pre-split, the shareholder now owned 1 share.
Zacks Equity Research 05/15/2020 04:03 AM ET Applied DNA Reports 2020 Fiscal Second Quarter Financial Results Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug Zacks: Applied DNA Sciences Inc (NASDAQ:APDN) Receives ... Applied DNA Sciences Inc (NASDAQ:APDN) has received a consensus broker rating score of 3.00 (Hold) from the one analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation. Zacks has also assigned Applied DNA Sciences an industry rank of 148 out of 255 based on […] Zacks Small Cap Research - APDN: An DNA solution for ... By Grant Zeng, CFA NASDAQ:APDN Update on Fiscal 2017 First Quarter Financials On February 9, Applied DNA Sciences (NASDAQ:APDN) announced financial results for the fiscal first quarter ended December 31, 2016. Total revenue for the fiscal first quarter was $0.9 million, compared with $1.32 million reported in the first quarter of fiscal 2016, a decrease APDN News Today (Applied DNA Sciences) | MarketBeat
By Grant Zeng, CFA OTC:APDN We adjust our price target for Applied DNA Sciences (OTC:APDN) to $12 per share reflecting the Company’s recent 1-for-60 reverse stock split. On October 29, 2014, APDN announced a 1-for-60 reverse split of its common stock. The Company’s common stock will trade on a split-adjusted basis under new CUSIP number 03815U 201 and temporary symbol "APDND."
Applied DNA Sciences up 181% on use of ... - Seeking Alpha Nov 12, 2019 Analyst Information for Applied DNA Sciences Inc. Consensus Rating for APDN is STRONG BUY: Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).